Remove Cardio Oncology Remove Cardiovascular Disease Remove Transplant
article thumbnail

American College of Cardiology (ACC) Program Set for Cardiac Oncology Conference, “Advancing the Cardiovascular Care of the Oncology Patient”

DAIC

After two full days covering a wide range of issues and experts, the final day will include a joint session with the American College of Cardiology ( ACC ) and the American Society of Clinical Oncology ( ASCO ). Cardio-Oncology Educational Training: What Do I Need to Learn? How to Structure?:

article thumbnail

Highlights of ACC 2024

Cardiology Update

Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes.

Angina 52